This list is an analysis based on recent market events. It's not an investment recommendation.
About
GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia. It offers tarhet and biomarker discovery; AI digital pathology; single cell analysis; and spatial and in-situ transcriptomics services; and SPACEINSIGHT, a cutting-edge cloud based integrated analysis platform. It serves hospitals, pharmaceutical companies, and researchers. The company was founded in 2018 and is headquartered in Seoul, South Korea.
The current price of 389030.KQ is ₩1,098 KRW — it has decreased by -6.15% in the past 24 hours. Watch Geninus stock price performance more closely on the chart.
What is Geninus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Geninus stocks are traded under the ticker 389030.KQ.
Is Geninus stock price growing?▼
389030.KQ stock has fallen by -17.75% compared to the previous week, the month change is a -47.46% fall, over the last year Geninus has showed a -52.88% decrease.
What is Geninus market cap?▼
Today Geninus has the market capitalization of 36.62B
What is Geninus revenue for the last year?▼
Geninus revenue for the last year amounts to 6.46B KRW.
What is Geninus net income for the last year?▼
389030.KQ net income for the last year is -10.61B KRW.
How many employees does Geninus have?▼
As of November 3, 2026, the company has 60 employees.
In which sector is Geninus located?▼
Geninus operates in the Energy sector.
When did Geninus complete a stock split?▼
The last stock split for Geninus was on July 13, 2022 with a ratio of 2:1.